Epilepsy Research
Volume 26, Issue 1 , Pages 295-304 , December 1996

Kindling with clozapine: behavioral and molecular consequences

  • J.R. Stevens

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 (503) 678-1524; fax: +1 (503) 678-3216.
    • Departments of Neurology and Psychiatry, Oregon Health Sciences University, Portland, OR 97201, USA
    • ,
  • D. Denney

      Affiliations

    • Departments of Neurology and Psychiatry, Oregon Health Sciences University, Portland, OR 97201, USA
    • ,
  • P. Szot

      Affiliations

    • Geriatric Research, Education and Clinical Center (GRECC), Veterans Affairs Medical Center, Seattle, WA 98108, USA
    • Department of Psychiatry and Behavioral Science, University of Washington, Seattle, WA 98195, USA

Received 22 October 1995 ,Accepted 5 December 1995.

References 

  1. Ansari F, Nakabeppu Y, Robertson GS. Contrasting effects of chronic clozapine, seroquel and haloperidol administration on FosB expression in the forebrain. In: Abs. Annu. Meet. Soc. Neurosci. 3:1995;p. 1708 Ansari F, Nakabeppu Y, Robertson GS. Contrasting effects of chronic clozapine, seroquel and haloperidol administration on FosB expression in the forebrain. In: Abs. Annu. Meet. Soc. Neurosci. 3:1995;p. 667.18
  2. Ackenheil M. Clozapine-pharmacokinetic investigations and biochemical effects in man. Psychopharmacology. 1989;99:S32–S37
  3. Berman I, Zalma A, DuRand CJ, Green AI. Clozapine-induced myoclonic jerks and drop attacks. J. Clin. Psychiatry. 1992;53:329–330 letter
  4. Bogerts B, Meertz E, Schonfeldt-Bausch R. Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Arch. Gen. Psychiatry. 1985;42:784–791
  5. Bruton CJ, Crow TJ, Frith CD, Johnstone EC, Owens DG, Roberts GW. Schizophrenia and the brain: A prospective clinico-neuropathological study. Psychol. Med. 1990;20:285–304
  6. Burt R, Enna SJ, Creese I, Snyder SH. Dopamine receptor binding in the corpus triatum of mammalian brain. In: Proc. Natl. Acad. Sci. USA. 72:1975;p. 4655–4659
  7. Carlsson A. Antipsychotic drugs, neurotransmitters, and schizophrenia. Am. J. Psychiatry. 1978;135:165–173
  8. Charlton M. Myoclonic Seizures. In: Assen, Netherlands: Excerpta Medica, Roche Medical Monograph Series Van Gorcum, Publishers; 1975;p. 167
  9. Chiodo LA, Bunney BS. Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J. Neurosci. 1983;3:1607–1619
  10. Curran T, Gordon MB, Rubino KL, Sambucetti LSC. Isolation and characterization of the c-fos (rat) cDNA and analysis of post-translational modifications in vitro. Oncogene. 1987;2:74–87
  11. Denney D, Stevens JR. Clozapine and seizures. Biol. Psychiatry. 1995;37:427–433
  12. Deutch AY, Ongur D, Duman RS. Antipsychotic drugs induce fos protein in the thalamic paraventricular nucleus: A novel locus of antipsychotic drug action. Neuroscience. 1995;66:337–382
  13. Devinsky O, Honigfeld G, Patin J. Clozapine-related seizures. Neurology. 1991;41:369–371
  14. Farde L, Nordstrom AL, Wiesel FA, Pauli S, Halldin C, Sedvall G. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch. Gen. Psychiatry. 1992;49:538–544
  15. Ferre S, Artigas F. Clozapine decreases decreases serotonin extracellular levels in the nucleus accumbens by a dopamine receptor-independent mechanism. Neurosci. Lett. 1995;187:61–64
  16. Goddard GV, McIntyre GC, Leech CK. A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol. 1969;25:295–330
  17. Gunther W, Baghai T, Naber D, Spatz R, Hippius H. EEG alterations and seizures during treatment with clozapine. A retrospective study of 283 patients. Pharmacopsychiatry. 1993;26:69–74
  18. Guo N, Klitenick MA, Tham CS, Fibiger HC. Receptor mechanisms mediating clozapine induced c-fos expression in the forebrain. Neuroscience. 1995;65:747–756
  19. Hall H, Halldin C, Nyberg S, Farde L, Sedvall G. Effect of clozapine and risperidone on 5HT2 and D2-dopamine receptor binding in the post mortem human brain. An autoradiographic study. Eur. Neuropsychopharmacol. 1995;5:19–25
  20. Hand TH, Hu KT, Wang RY. Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons. Brain Res. 1987;415:257–269
  21. Handforth A, Treiman DM. Functional mapping of bicuculline-induced brainstem and myoclonic seizures: A C-2-deoxyglucose study. Soc. Neurosci. Abstr. 1993;19:248.9
  22. Hatton GI. Phasic bursting activity of rat paraventricular neurones in the absence of synaptic transmission. J. Physiol. (Lond.). 1982;327:273–284
  23. Hoffman DC. Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats. J. Neural Transm. 1992;89:1–10
  24. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 1991;148:1301–1308 review
  25. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch. Gen. Psychiatry. 1988;45:789–796
  26. Kawakami M, Terasawa E, Ibuki T. Changes in multiple unit activity of the brain during the estrous cycle. Neuroendocrinology. 1970;6:30–48
  27. Killam KF, Killam EK. Drug action on pathways involving the reticular formation. In:  Jasper HH editors. Reticular Formation of the Brain. Boston: Little Brown; 1958;
  28. Koukkou M, Angst J, Zimmer D. Paroxysmal EEG activity and psychopathology during the treatment with clozapine. Pharmakopsychiatry Neuropsychopharmakology. 1979;12:173–183
  29. Lang A, Vasar E, Soosaar A, Harro J. The involvement of sigma and phencyclidine receptors in the action of antipsychotic drugs. Pharmacol. Toxicol. 1992;71:132–138
  30. Leysen JE, Janssen P, Megens A, Schotte A. Risperidone: A novel antipsychotic with balanced serotonin dopamine antagonism, receptor occupancy profile and pharmacologic activity. J. Clin. Psychiatry. 1994;55:5–12
  31. Lindstrom LH. The effect of long-term treatment with clozapine in schizophrenia: A retrospective study in 96 patients treated with clozapine for up to 13 years. Acta Psychiatr. Scand. 1988;77:524–529
  32. Liukkonen J, Koponen HJ, Nousiainen U. Clinical picture and long-term course of epileptic seizures that occur during clozapine treatment. Psychiatry Res. 1992;44:107–112
  33. MacGibbon GA, Lawlor PA, Bravo R, Dragunow M. Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Brain Res. Mol. Brain Res. 1994;23:21–32
  34. Markowitz JC, Brown RP. Seizures with neuroleptics and antidepressants. Gen. Hosp. Psychiatry. 1987;9:135–141 review
  35. May PR, Tuma H, Dixon WJ, Yale C, Thiele DA, Kraude WH. Schizophrenia: A follow up study of the results of five forms of treatment. Arch. Gen. Psychiatry. 1981;38:776–784
  36. McInerney SC, Hoffman DC, Donovan H, Cornfield LJ, Meade RJ, Cassella JV, et al. Effects of antipsychotics on the pentylenetetrazole (PTZ) seizure threshold relative to in vivo potency may be predictive of clinical seizure liability. Soc. Neurosci. Abstr. 1994;2:726.6
  37. Meltzer H. Clozapine: Clinical advantages and biological mechanisms. In:  Schulz SC,  Tamminga CA editor. Schizophrenia: A Scientific Focus. New York, NY: Oxford University Press; 1988;p. 302–309
  38. Meltzer HY, Bastani B, Kwon KY, Ramirez LF, Burnett S, Sharpe J. A prospective study of clozapine in treatment-resistant schizophrenic patients. Psychopharmacology. 1989;99:S68–72
  39. O'Byrne KT, Knobil E. Electrophysiological approaches to gonadotrophin releasing hormone pulse generator activity in the rhesus monkey. Hum. Reprod. 1993;8(Suppl. 2):37–40
  40. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch. Gen. Psychiatry. 1990;47:1023–1028
  41. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. New York, NY: Academic Press; 1982;
  42. Pinel JP, van Oot PH. Generality of the kindling phenomenon: Some clinical implications. Can. J. Neurol. Sci. 1975;2:467–475
  43. Post RM, Kennedy C, Shinohara M, Squillace K, Miyaoka M, Suda S, et al. Metabolic and behavioral consequences of lidocaine-kindled seizures. Brain Res. 1984;324:295–303
  44. Pranzatelli MR, Tate E, Huang R, Haas H, Bodensteiner J, Ashwal S, et al. Neuropharmacology of progressive myoclonus epilepsy: Response to 5-hydroxy-l-tryptophan. Epilepsia. 1995;36:783–791
  45. Randrup A, Munkvad I. Special antagonism of amphetamine-induced abnormal behavior. Inhibition of stereotyped activity with increase of some normal activities. Psychopharmacologia. 1965;7:416–422
  46. Robertson GS, Fibiger HC. Neuroleptics increase c-fos expression in the forebrain: Contrasting effects of haloperidol and clozapine. Neuroscience. 1992;46:315–328
  47. Rogawski MA. The NMDA receptor, NMDA antagonists and epilepsy therapy. A status report. Drugs. 1992;44:279–292 review
  48. Rodrigues AA, Jansen FP, Leurs R, Timmerman H, Prell GD. Interaction of clozapine with the histamine H3 receptor in ratbrain. Br. J. Pharmacol. 1995;114:1523–1524
  49. Seeman P, Lee T, Chau-Wong M, Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature. 1976;261:717–719
  50. Squires RF, Saederup E. A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: More support for a continuum hypothesis of functional psychosis. Neurochem. Res. 1991;16:1099–1111
  51. Stevens JR. The EEG spike: Signal of information transmission?. Ann. Neurol. 1977;1:309–314
  52. Stevens JR. The Yin and Yang of Seizures and Psychosis. Biol. Psychiatry. 1995;37:425–426
  53. Sumiyoshi T, Kido H, Sakamoto H, Urasaki K, Suzuki K, Yamaguchi N, et al. Time course of dopamine-D2 and serotonin-5-HT2 receptor occupancy rates by haloperidol and clozapine in vivo. Jpn. J. Psychiatry Neurol. 1993;47:131–137
  54. Szot P, Dorsa DM. Cytoplasmic and nuclear vasopressin RNA in hypothalamic and extrahypothalamic neurons of the Brattleboro rat: An in situ hybridization study. Mol. Cell. Neurosci. 1992;3:224–236
  55. Tiedtke PI. MK801-induced stereotypy and its antagonism by neuroleptics. J. Neural Transm. 1990;81:173–182
  56. Wasterlain CG, Fairchild MG, Bronstein JM, Farber DB. In:  Wada JA editors. Kindling. 3:New York, NY: Raven Press; 1986;p. 55–71

PII: S0920-1211(96)00061-7

Epilepsy Research
Volume 26, Issue 1 , Pages 295-304 , December 1996

Article Tools